Form 8-K - Current report:
SEC Accession No. 0001625297-25-000021
Filing Date
2025-03-04
Accepted
2025-03-04 16:14:24
Documents
17
Period of Report
2025-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K indv-20250302.htm   iXBRL 8-K 40701
2 EX-10.1 ex101amendedandrestatedrel.htm EX-10.1 174035
3 EX-10.2 ex102-jciaffoniemploymenta.htm EX-10.2 127376
4 EX-99.1 a991-pressrelease.htm EX-99.1 13141
8 image_0.jpg GRAPHIC 28373
  Complete submission text file 0001625297-25-000021.txt   572230

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20250302.xsd EX-101.SCH 1773
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20250302_lab.xml EX-101.LAB 21615
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20250302_pre.xml EX-101.PRE 12502
19 EXTRACTED XBRL INSTANCE DOCUMENT indv-20250302_htm.xml XML 2737
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37835 | Film No.: 25704555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)